SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: DOLLAR BILL who wrote (962)8/1/1999 8:31:00 PM
From: Daniel Goldstein  Read Replies (1) | Respond to of 998
 
When does earnings report come out?



To: DOLLAR BILL who wrote (962)8/5/1999 12:44:00 PM
From: LLCF  Read Replies (1) | Respond to of 998
 
Everyone see the CEPH financing? $100 million in convertible preferred stock to be sold 144A. Should give them tons of flexibility to redeem past financings, and pump up the future provigil trials.
Market giving it a bit of a whack.

DAK



To: DOLLAR BILL who wrote (962)7/31/2000 11:57:45 AM
From: LLCF  Respond to of 998
 
I was wondering what took this thing to those heights it achieved.... Provigil approval for ADHD was priced in?? This market is wacky.

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News